Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Reduced loss of hand bone density with prednisolone in early rheumatoid arthritis: results from a randomized placebo-controlled trial.

Haugeberg G, Strand A, Kvien TK, Kirwan JR.

Arch Intern Med. 2005 Jun 13;165(11):1293-7.

PMID:
15956010
3.

Bone loss in patients with active early rheumatoid arthritis: infliximab and methotrexate compared with methotrexate treatment alone. Explorative analysis from a 12-month randomised, double-blind, placebo-controlled study.

Haugeberg G, Conaghan PG, Quinn M, Emery P.

Ann Rheum Dis. 2009 Dec;68(12):1898-901. doi: 10.1136/ard.2008.106484. Epub 2009 Apr 21. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.

PMID:
19386610
4.

Hand bone loss in patients with psoriatic arthritis: posthoc analysis of IMPACT II data comparing infliximab and placebo.

Hoff M, Kavanaugh A, Haugeberg G.

J Rheumatol. 2013 Aug;40(8):1344-8. doi: 10.3899/jrheum.121376. Epub 2013 Jun 15.

PMID:
23772084
5.

Hand bone loss measured by digital X-ray radiogrammetry is a predictor of joint damage in early rheumatoid arthritis.

Forslind K, Boonen A, Albertsson K, Hafström I, Svensson B; Barfot Study Group.

Scand J Rheumatol. 2009 Nov-Dec;38(6):431-8. doi: 10.3109/03009740902939376.

PMID:
19922017
6.

Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study.

Engvall IL, Svensson B, Tengstrand B, Brismar K, Hafström I; Better Anti-Rheumatic FarmacO Therapy Study Group.

Arthritis Res Ther. 2008;10(6):R128. doi: 10.1186/ar2542. Epub 2008 Nov 5.

8.

Bone turnover, joint damage and bone mineral density in early rheumatoid arthritis treated with combination therapy including high-dose prednisolone.

Verhoeven AC, Boers M, te Koppele JM, van der Laan WH, Markusse HM, Geusens P, van der Linden S.

Rheumatology (Oxford). 2001 Nov;40(11):1231-7.

PMID:
11709606
9.

Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.

Boers M, Verhoeven AC, Markusse HM, van de Laar MA, Westhovens R, van Denderen JC, van Zeben D, Dijkmans BA, Peeters AJ, Jacobs P, van den Brink HR, Schouten HJ, van der Heijde DM, Boonen A, van der Linden S.

Lancet. 1997 Aug 2;350(9074):309-18. Erratum in: Lancet 1998 Jan 17;351(9097):220.

PMID:
9251634
10.

Influence of cyclic intravenous pamidronate on proinflammatory monocytic cytokine profiles and bone density in rheumatoid arthritis treated with low dose prednisolone and methotrexate.

Van Offel JF, Schuerwegh AJ, Bridts CH, Bracke PG, Stevens WJ, De Clerck LS.

Clin Exp Rheumatol. 2001 Jan-Feb;19(1):13-20.

PMID:
11247319
11.

Adalimumab therapy reduces hand bone loss in early rheumatoid arthritis: explorative analyses from the PREMIER study.

Hoff M, Kvien TK, Kälvesten J, Elden A, Haugeberg G.

Ann Rheum Dis. 2009 Jul;68(7):1171-6. doi: 10.1136/ard.2008.091264. Epub 2008 Sep 18.

12.

Prevention of bone loss with risedronate in glucocorticoid-treated rheumatoid arthritis patients.

Eastell R, Devogelaer JP, Peel NF, Chines AA, Bax DE, Sacco-Gibson N, Nagant de Deuxchaisnes C, Russell RG.

Osteoporos Int. 2000;11(4):331-7.

PMID:
10928223
13.

Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis.

Güler-Yüksel M, Allaart CF, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, van Groenendael JH, Mallée C, de Bois MH, Breedveld FC, Dijkmans BA, Lems WF.

Ann Rheum Dis. 2009 Mar;68(3):330-6. doi: 10.1136/ard.2007.086348. Epub 2008 Mar 28.

PMID:
18375540
14.

A randomised trial of differentiated prednisolone treatment in active rheumatoid arthritis. Clinical benefits and skeletal side effects.

Hansen M, Podenphant J, Florescu A, Stoltenberg M, Borch A, Kluger E, Sørensen SF, Hansen TM.

Ann Rheum Dis. 1999 Nov;58(11):713-8.

17.

Establishment of age- and sex-adjusted reference data for hand bone mass and investigation of hand bone loss in patients with rheumatoid arthritis treated in clinical practice: an observational study from the DANBIO registry and the Copenhagen Osteoarthritis Study.

Ørnbjerg LM, Østergaard M, Jensen T, Hyldstrup L, Bach-Mortensen P, Bøyesen P, Thormann A, Tarp U, Bøhme WP, Lindegaard H, Poulsen UE, Schlemmer A, Graudal N, Rødgaard A, Espesen J, Kollerup GB, Glintborg B, Madsen OR, Jensen DV, Hetland ML.

Arthritis Res Ther. 2016 Feb 24;18:53. doi: 10.1186/s13075-016-0952-y.

18.
19.

Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?

van der Goes MC, Jacobs JW, Jurgens MS, Bakker MF, van der Veen MJ, van der Werf JH, Welsing PM, Bijlsma JW.

Osteoporos Int. 2013 Apr;24(4):1429-36. doi: 10.1007/s00198-012-2073-z. Epub 2012 Aug 2.

20.

[Clinical trial for differentiation between corticoid-induced osteoporosis and periarticular demineralization via digital radiogrammetry in patients suffering from rheumatoid arthritis].

Böttcher J, Pfeil A, Lehmann G, Heinrich B, Malich A, Hansch A, Petrovitch A, Mentzel HJ, Hein G, Kaiser WA.

Z Rheumatol. 2004 Dec;63(6):473-82. German.

PMID:
15605213

Supplemental Content

Support Center